A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res., 56: 4694-4701, 1996; and Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res., 56: 4686-4693, 1996.
Gallo
J M
JM
Hafeli
U
U
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D015251:Epirubicin / Q000008:administration & dosage*; D006801:Humans; D008280:Magnetics; D009369:Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin